STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $256,000 | -55.1% | 52,863 | -1.3% | 0.00% | -100.0% |
| Q4 2019 | $570,000 | +9.2% | 53,583 | +7.0% | 0.00% | 0.0% |
| Q3 2019 | $522,000 | +60.1% | 50,097 | +135.1% | 0.00% | – |
| Q2 2019 | $326,000 | +27.8% | 21,309 | +7.2% | 0.00% | – |
| Q1 2019 | $255,000 | +35.6% | 19,882 | +0.5% | 0.00% | – |
| Q4 2018 | $188,000 | -83.7% | 19,774 | -22.5% | 0.00% | -100.0% |
| Q3 2013 | $1,155,000 | – | 25,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 1,471,518 | $23,618,000 | 8.40% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 492,930 | $7,862,000 | 3.02% |
| Consonance Capital Management LP | 2,747,198 | $44,093,000 | 2.84% |
| NEXTHERA CAPITAL LP | 559,517 | $8,980,000 | 1.39% |
| Eventide Asset Management | 1,086,400 | $17,437,000 | 0.72% |
| Virtus ETF Advisers LLC | 45,850 | $736,000 | 0.65% |
| KNOTT DAVID M | 90,000 | $1,445,000 | 0.54% |
| Polar Capital LLP | 1,912,605 | $30,697,000 | 0.18% |
| Artal Group S.A. | 400,000 | $6,420,000 | 0.14% |
| J. Goldman & Co LP | 100,000 | $1,605,000 | 0.08% |